SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
26-Jun-24 4:28 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 24-Jun-24 | Option Exercise | 32,450 | $80.76 | $2,620,610.00 | 116% 28.04K to 60.49K | |
26-Jun-24 4:28 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 24-Jun-24 | Planned Option Sale | 32,450 | $220.69 | $7,161,360.00 | (54%) 60.49K to 28.04K | |
23-May-24 5:36 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 21-May-24 | Grant | 4,720 | -- | -- | 10% 45.03K to 49.75K | |
24-May-23 6:28 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 23-May-23 | Grant | 4,190 | -- | -- | 10% 40.84K to 45.03K | |
27-Feb-23 4:13 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 23-Feb-23 | Option Exercise | 136 | -- | -- | < 1% 27.9K to 28.04K | |
26-May-22 9:32 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 24-May-22 | Grant | 4,980 | -- | -- | 14% 35.86K to 40.84K | |
27-May-21 8:05 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 25-May-21 | Grant | 5,120 | -- | -- | 17% 30.74K to 35.86K | |
01-Sep-20 9:44 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 31-Aug-20 | Market Purchase | 12,800 | $78.26 | $1,001,720.00 | 71% 17.94K to 30.74K | 5% |
29-May-20 6:32 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 27-May-20 | Grant | 4,300 | -- | -- | 32% 13.64K to 17.94K | |
24-Apr-20 4:26 PM View: | Avery Dennison Corporation (AVY) | 23-Apr-20 | Option Exercise | 1,414 | $107.56 | $152,090.00 | 8% 17.27K to 18.68K | 39% |
05-Feb-20 3:04 PM View: | Avery Dennison Corporation (AVY) | 03-Feb-20 | Option Exercise | 5,027 | $38.18 | $191,931.00 | 29% 17.27K to 22.3K | |
05-Feb-20 3:04 PM View: | Avery Dennison Corporation (AVY) | 03-Feb-20 | Market Option Sale | 5,027 | $132.72 | $667,183.00 | (23%) 22.3K to 17.27K | (12%) |
06-Jun-19 5:47 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 04-Jun-19 | Grant | 4,430 | -- | -- | 48% 9.21K to 13.64K | |
02-May-19 7:38 PM View: | Avery Dennison Corporation (AVY) | 01-May-19 | Option Exercise | 1,977 | $109.63 | $216,738.00 | 13% 15.29K to 17.27K | 35% |
28-Nov-18 5:01 PM View: | Avery Dennison Corporation (AVY) | 27-Nov-18 | Option Exercise | 2,000 | $20.64 | $41,280.00 | 13% 15.29K to 17.29K | |
28-Nov-18 5:01 PM View: | Avery Dennison Corporation (AVY) | 27-Nov-18 | Market Option Sale | 2,000 | $93.00 | $186,000.00 | (12%) 17.29K to 15.29K | (59%) |
07-Jun-18 9:13 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 05-Jun-18 | Grant | 4,300 | -- | -- | 88% 4.91K to 9.21K | |
02-May-18 6:05 PM View: | Avery Dennison Corporation (AVY) | 01-May-18 | Option Exercise | 3,066 | $104.80 | $321,317.00 | 25% 12.23K to 15.29K | 40% |
30-Aug-17 6:02 PM View: | Avery Dennison Corporation (AVY) | 30-Aug-17 | Option Exercise | 1,702 | $52.12 | $88,699.70 | 10% 16.3K to 18.0K | |
30-Aug-17 6:02 PM View: | Avery Dennison Corporation (AVY) | 30-Aug-17 | Market Option Sale | 1,702 | $94.00 | $159,988.00 | (9%) 18.0K to 16.3K | (54%) |
30-Aug-17 6:02 PM View: | Avery Dennison Corporation (AVY) | 28-Aug-17 | Option Exercise | 298 | $52.12 | $15,530.30 | 2% 16.3K to 16.6K | |
30-Aug-17 6:02 PM View: | Avery Dennison Corporation (AVY) | 28-Aug-17 | Market Option Sale | 298 | $94.00 | $28,012.00 | (2%) 16.6K to 16.3K | (54%) |
08-Jun-17 6:31 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 06-Jun-17 | Grant | 2,050 | -- | -- | 72% 2.86K to 4.91K | |
03-May-17 3:08 PM View: | Avery Dennison Corporation (AVY) | 01-May-17 | Option Exercise | 2,245 | $83.42 | $187,278.00 | 16% 14.06K to 16.3K | 73% |
14-Oct-16 4:22 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Oct-16 | Market Purchase | 27,900 | $37.00 | $1,032,330.00 | 100% 0 to 27.9K | 126% |
09-Aug-16 1:06 PM View: | Avery Dennison Corporation (AVY) | 08-Aug-16 | Option Exercise | 2,000 | $67.79 | $135,590.00 | 14% 14.06K to 16.06K | |
09-Aug-16 1:06 PM View: | Avery Dennison Corporation (AVY) | 08-Aug-16 | Market Option Sale | 2,000 | $78.61 | $157,220.00 | (12%) 16.06K to 14.06K | (80%) |
08-Jun-16 8:07 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 06-Jun-16 | Grant | 760 | -- | -- | 36% 2.1K to 2.86K | |
02-May-16 5:53 PM View: | Avery Dennison Corporation (AVY) | 29-Apr-16 | Option Exercise | 2,620 | $72.82 | $190,788.00 | 23% 11.44K to 14.06K | 94% |
06-Jan-16 4:07 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 04-Jan-16 | Grant | 2,100 | -- | -- | 100% 0 to 2.1K | |
03-Nov-15 4:18 PM View: | Avery Dennison Corporation (AVY) | 02-Nov-15 | Option Exercise | 2,000 | $59.47 | $118,930.00 | 17% 11.44K to 13.44K | |
03-Nov-15 4:18 PM View: | Avery Dennison Corporation (AVY) | 02-Nov-15 | Market Option Sale | 2,000 | $64.88 | $129,760.00 | (15%) 13.44K to 11.44K | (115%) |
04-May-15 4:04 PM View: | Avery Dennison Corporation (AVY) | 01-May-15 | Option Exercise | 1,874 | $55.84 | $104,644.00 | 20% 9.56K to 11.44K | 147% |
28-Apr-15 12:34 PM View: | Avery Dennison Corporation (AVY) | 26-Apr-15 | Option Exercise | 524 | $51.77 | $27,127.50 | 6% 9.04K to 9.56K | 166% |
19-Mar-15 7:45 PM View: | Allergan Inc. (AGN) | 17-Mar-15 | Disposition | 165,658 | -- | -- | (58%) 285.28K to 119.63K | |
19-Mar-15 7:45 PM View: | Allergan Inc. (AGN) | 17-Mar-15 | Disposition | 119,625 | -- | -- | (100%) 119.63K to 0 | |
24-Feb-15 9:52 PM View: | Allergan Inc. (AGN) | 20-Feb-15 | Payment of Exercise | 720 | $234.00 | $168,480.00 | (< 1%) 400.55K to 399.83K | (1%) |
24-Feb-15 9:52 PM View: | Allergan Inc. (AGN) | 20-Feb-15 | Option Exercise | 1,379 | -- | -- | < 1% 399.17K to 400.55K | |
19-Mar-15 7:45 PM View: | Allergan Inc. (AGN) | 12-Feb-15 | Gift | 114,548 | -- | -- | (29%) 399.83K to 285.28K | |
13-May-14 5:09 PM View: | Edwards Lifesciences Corp. (EW) | 09-May-14 | Grant | 2,342 | -- | -- | 5% 51.24K to 53.58K | |
02-May-14 2:07 PM View: | Avery Dennison Corporation (AVY) | 01-May-14 | Option Exercise | 1,015 | $48.50 | $49,227.50 | 13% 8.03K to 9.04K | 176% |
29-Apr-14 1:35 PM View: | Avery Dennison Corporation (AVY) | 28-Apr-14 | Option Exercise | 391 | $48.82 | $19,088.60 | 5% 7.63K to 8.03K | 175% |
29-Apr-14 1:35 PM View: | Avery Dennison Corporation (AVY) | 26-Apr-14 | Option Exercise | 523 | $48.71 | $25,472.70 | 7% 7.11K to 7.63K | 175% |
13-Feb-14 5:49 PM View: | Allergan Inc. (AGN) | 12-Feb-14 | Option Exercise | 252,000 | $36.15 | $9,109,800.00 | 63% 399.17K to 651.17K | |
13-Feb-14 5:49 PM View: | Allergan Inc. (AGN) | 12-Feb-14 | Option Sale | 252,000 | $123.12 | $31,025,600.00 | (39%) 651.17K to 399.17K | (93%) |
17-May-13 5:11 PM View: | Edwards Lifesciences Corp. (EW) | 15-May-13 | Grant | 2,811 | -- | -- | 6% 48.43K to 51.24K | |
01-May-13 5:29 PM View: | Edwards Lifesciences Corp. (EW) | 01-May-13 | Market Purchase | 3,000 | $62.95 | $188,850.00 | 7% 45.43K to 48.43K | 315% |
29-Apr-13 7:35 PM View: | Avery Dennison Corporation (AVY) | 26-Apr-13 | Option Exercise | 912 | $41.51 | $37,861.70 | 15% 6.2K to 7.11K | 215% |
23-Apr-13 2:49 PM View: | Avery Dennison Corporation (AVY) | 22-Apr-13 | Option Exercise | 436 | $40.85 | $17,810.60 | 8% 5.76K to 6.2K | 220% |
05-Oct-12 7:21 PM View: | Allergan Inc. (AGN) | 05-Oct-12 | Option Exercise | 307,956 | $41.24 | $12,700,100.00 | 77% 399.15K to 707.11K |